云顶新耀首席执行官罗永庆表示：“evm14成功获得美国fda ind批准，成为公司首款自研进入国际临床阶段的mrna肿瘤治疗性疫苗，标志着云顶新耀在mrna ...

本文聚焦癌症 mRNA 疫苗，阐述其作为新兴免疫疗法，在临床应用中的进展与挑战。介绍了优化策略、作用机制、临床试验成果及联合疗法，分析现存问题并展望未来，为癌症免疫治疗研究提供全面参考。

全球生物医药领域创新浪潮中，我国国产疫苗不断取得创新突破。5月19日，艾美疫苗公告，公司研发的mrna带状疱疹疫苗，继2025年3月获美国fda批准 ...

Lindsay Maher with Informed Choice Iowa, a group founded in 2017 in opposition to vaccine requirements and health mandates, said there were specific concerns about mRNA vaccines as “gene therapy ...

A bill to make it a crime to administer mRNA vaccines in Iowa — like the Moderna and Pfizer COVID shots — has cleared initial review in the Iowa Senate.

Lindsay Maher with Informed Choice Iowa, a group founded in 2017 in opposition to vaccine requirements and health mandates, said there were specific concerns about mRNA vaccines as “gene therapy ...

Iowa lawmakers advanced a bill Monday banning the administration of mRNA vaccines. The bill, Senate File 360, would outlaw any person in the state of Iowa from administering an mRNA and would impose ...

该综述系统总结了癌症 mRNA 疫苗的临床进展与挑战：通过优化 mRNA 结构（如5'帽、Poly(A)尾修饰）和递送载体（如脂质纳米颗粒），疫苗可精准激活抗 ...

研究人员开发了一套完整的mRNA实验室制备方案，涵盖序列设计、DNA模板制备、体外转录(IVT)、脂质纳米颗粒(LNP)封装及细胞转染等关键步骤。该方案通过PCR等简易技术实现小规模生产，配套质量控制体系可确保mRNA纯度与完整性，为疫苗研发、蛋白质替代疗法及细胞基因治疗等 preclinical 研究提供了 ...